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Summary: It is current practice to record the performance of immunoassays by means of pi^ecision profiles
(according to Ekins\ in which the Variation coefficient (relative Standard deviation) is plotted against the
analyte concentration. On the other hand, precision profiles are only occasionally used for evaluating the
performance of conventional clinical-chemical methods.
It is relatively uncommon to find bias plotted against analyte concentration, presumably because this type of
analysis requires reference specimens, whose true analyte concentrations are known or guaranteed by reference
methods. If the relative systematic variations are plotted against the true analyte concentrations, and a
confidence interval is added to the resulting regression curve, the result is a "bias profile"; if tolerance limits
are added, the result is a "deviation profile".
The present work describes the preparation of specimens, which can be used to provide experimental data
for the three performance profiles. A Computer program is used to construct the precision profile, bias profile
and/or deviation profile. The mathematical^statistical basis of the program is described in detail.
For evaluation of the statistical procedure, three analytes and six methods were used: determination of sodium
activity/concentration with aii ion sensitive electrode and by flame photometry; determination of creatinine
by a manual enzymic and a mechanized Jaffe method; determination of thyrotropin by radioimmunoassay
and by luminescence immunoassay.
Different purposes are served by bias and deviation profiles. Thus, bias profiles can be used to compare the
bias of two methods, whereas a deviation profile can be used to define the analytical ränge of a method. If
the acceptable limits of deviation are added to the deviation profile, then the useful analytical ränge of the
method is immediately apparent.
importance is the possible dependence of s on the
In a study of the reliability criteria of chemical ana- concentration of determinand". In clinical chemistry,
lytical methods, Wilson (2) refers to a 1963 mono- the dependence of analytical precision and accuracy
graph by Nalimov (1) and states: "A further point of on the concentration ofthe analyte in the matrix was
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apparently first described and analysed graphically in
1967 (3). In 1971, Broughton et al. (4) evaluated a
number of autoanalyser methods and showed, in prac-
tically every case, that an increase in the concentration
of an analyte was accompanied by an increase in the
Standard deviation and a decrease in the Variation
coefficient. In 1974, Aronson et al. (5) reported similar
studies with six "automated" analytical Systems. In
all the tested methods, the Standard deviation in-
creased with the concentration of analyte, whereas
the Variation coefficient at first decreased, then in-
creased again at higher analyte concentrations.
In the same year, Rodbard (6) investigated the dose-
response curves of various radioimmunoassays, and
reported that the relative Standard error depended on
the concentration. If the Standard deviations or Var-
iation coefficients are plotted against the analyte coil··
centrations in an x/y diagram, and the points are
fitted to a curve, the resulting plot is the "precision
profile" described by Ekins (7). It is possible to con-
struct intra-a'ssay/intra-sample, intra-assay/inter-sam-
ple, inter-assäy/intra-sample and other forms of pre-
cision profile. Ekins (8) recommended the use of these
curves for optimizing the reagents, the experimental
procedures and the instrumental settings. In recent
years, many authors have used precision .profiles to
describe the performance of immunoassays (9 — 12).
Hitherto, the plot of Xj/Sj (or Xi/CVj), has been drawn
"intuitively" (i.e. manually). Recently, Sadler et al.
(13) formulated a model, which permits an approxi-
mate estimation or graphic representation of variance:
2
 ( ) = (ß, + ß2H)< (Eq. 1)
where 2( ) represents variance, H represents the
concentration, and ß,, ß2 and I are parameters.
It has been shown that a good approximation results
if I is assigned a value of 3.
In general, the following can be stated: if H = 0, the
variance corresponds to the background "noise" of
the analytical system, i. e. imprecision of the blank
value. At measurable analyte concentrations, random
errors (imprecision) are accordingly always the same
or larger than the scatter around the blank value.
Referring to the deviations from accuracy (bias),
Mandel (14) states: "depends on two factors: the con-
centration of the analyte in the sample, and the matrix
in which this analyte finds itself in the sample ...
Consequently, the accuracy of an analytical method
should never be determined on a single sample, but
rather on a set of samples covering the entire ränge
of concentrations of the analyte and representing äs
many äs possible of the matrix configurations that
may typically be expected in the Situation under
study".
The analytical calibration function, starting from a.
"single component model" was defined by Currie (l 5)
äs:
= (y - B)/A (Eq. 2)
where B = blank, A = calibrator factor, = esti-
mated concentration, y = Instrument response.
The "proportional bias" causes A to change, whereas
the "constant bias" causes B to change. In general,
however, the following applies: "the inaccuracy is
understood to . . . consist of two components, the bias
and the imprecision . . . any paf ticular combination to
replace bias and STD with a single index ... is riot
recommended; it must be viewed äs a two^component
vector". The concept of "total errors" (see, e. g. L c.
(26)) should be abandoned.
If, for the purposes of determining bias, the analyte
concentration in speciiiien i is determined n times,
then the average value, Xj, is subject to analytical
imprecision. The difference (x, — must therefore
be supplemented with a confidence interval, which
can be estimated (14):
s s(x - ) - ta — - < bias < (x - ) + t« —l/n J/n
(Eq. 3)
where ta is the critical value of the t-distribution
(Student), for probability l -a, and n-1 degrees of
freedom. Xi represents the estimator of the expected
value (in the method under investigation), whereas ^
represents the true value (or assigned value, or ref-
erence value, etc.).
If bias is determined for several analyte concentra-
tions over the total relevant ränge, a "bias profile"
analogous to the "imprecision profile" can be cöfi-
structed.
If, however, the confidence limits (Eq. 3) are changed
to tolerance limits,
( — )-^ l +-< deviation < (x —
n
!+-
(Eq.4)
and the bias, together with these tolerance limits, is
plotted over the relevant concentration ränge, then a
different profile is obtained, for which we propose the
name "deviation profile".
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The limits of this deviation profile run parallel to
those of the bias profile. The limits of the deviation
profile are wider than those of the bias profile, because
the bias profile represents only the systematic devia-
tion of the method, whereas the deviation profile
includes both the systematic and random deviations.
This is explained more fully in the appendix.
The profiles of bias and deviation serve different
purposes. For example, bias profiles can be used to
compare the bias of two methods, whereas a deviation
profile can be used to define the useful analytical
r nge of a method. For the latter purpose, the ac-
ceptable limits of deviation are drawn on the graph.
The r nge of analyte concentrations lying within these
deviation limits (i. e. the useful analytical r nge of the
method) is then immediately apparent. This is also
described more fully in the appendix.
Figure l shows model graphical representations of
these concepts, based on the data in table l. In figure
l a, Standard deviation is plotted against the average
value; it is assumed that each average value was
calculated from 10 separate measurements. The points
are joined by a (slightly convex) curve, corresponding
to Eq. 1. If this representation is based on relative
values, i. e. the Ordinate becomes the percentage Var-
iation coefficient, a different plot is obtained (fig. Ib).
The bias of these model results is shown by figure Ic,
where the points are joined by a straight line corre-
sponding to the regression function of table 1. The
accompanying Standard deviations are determined ac-
cording to Eq. 31)· The resulting "bias profile" is
hatched in figure Ic, and it can be seen that this
becomes slightly wider s μ increases. If the relevant
Standard deviations are determined according to
Eq. 42), the tolerance limits (dashed lines) are ob-
tained. This "deviation profile" is about 3.3 times
wider than the bias profile.
The relative preseiitatiom of the same inaterial is
shown in figure Id. It contains all the Information of
the three previous graphs, and shows at a glance the
limits of performance of the analytical method. This
model can be translated into practice s follows:
1. Several (at least 3) specimens must be available,
whose analyte concentrations (μ) are'known exactly,
e. g. cbntrol specimens are prepared by weighing the
pure analyte, of their concentrations are determined
with a definitive or reference method. The analyte
Tab. 1. Model population of results. The average values (x)
were calculated from the regression function, and the
Standard deviation (s) was determined according to 1. c.
(13).
μ = true value; CV = coefficient of Variation; CB =
coefficient of bias
μ χ s CV
(Arb. units) (Arb. units) (Arb. units)
CB
10
30
50
70
90
9.5
30.0
50.5
71.0
91.5
.043
.138
.236
.336
.439
10.98
3.79
2.45
1.88
1.57
-5.0
0
1.0
1.43
1.66
') s χ tq/l/n ~ s χ 0.715;
2) s χ t« )/l 4- l/n = s χ 2.373;
t« (two-sided, for n - l = 9) = 2.2622
(see, e. g. Scientific Tables Geigy, 8th edition, Vol. 3. Signif-
icance limits of Siudenfs distribution).
Regression function: χ = 1.025 μ - 0.75; β, = 1.0;
 2 = 0.003
concentrations of these specimens must cover either
the whole of the analytically relevant concentration
r nge, or that part of the r nge intended for current
use.
2. Using the method under test, the chosen analyte is
determined several times (e.g. 10 times) in each spec-
imen. χ and s are calculated from the resulting data,
thereby confirming (e. g. by means of the Kolmogorov-
Smirnov test) that the data in fact show a normal
distribution.
3. Using the average values and the Standard devia-
tions or Variation coefficients, the parameters i and
2 are estimated with the aid of Eq. l, and a precision
profile is constructed.
4. Using Eq. 3 and the average and assigned values,
the bias and the accompanying interval are calculated
for each concentration, and the "bias profile" is plot-
ted.
5. Using Eq. 4 and the average and assigned values,
the bias and the accompanying tolerance interval are
calculated for each concentration, and the "deviation
profile" is plotted. The acceptable limits of deviation
are added to this graph, so that the useful analytical
r nge of the method can be read off.
6. Using other specimens with different matrices, these
experimental procedures are repeated, preferably by
several different laboratories.
Using this procedure, the following characteristics of
the method are determined:
a) the quantitative relationship between imprecision
and the assigned (true) value;
b) the quantitative relationship between bias and the
assigned (true) concentration; and
c) the upper and lower limits of the useful analytical
r nge, which depend on the acceptable limits of de-
viation.
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We have tested this concept on three different ana-
lytes, using different analytical procedures.
To 10 ml samples of this sohition were added 0, l, 2, 3 ... 10 mJ
of double distilled water, and the concentration of each dilution
was calculated from: 173.989 mmol/1 per total volume (ml)
χ l O"1 = cNa mmol/1.
2. Materials and Methode
The analytical apparatus and commercial test kits employed in
this work were used strictly in accordance with the instructions
of the manufacturers. Calibrated apparatus was used for all
Volumetrie work.
2.1 Sodium determination in aqueous NaCl Solutions
Two analytical Systems were used for the determination of
sodium concentration or activity:
2.1.1 A utomatic flame photometer, Eppendorf A FM 5051
The apparatus automatically determines the concentrations of
sodium, potassium and calcium in serum, and sodium and
potassium in urine. Undiluted specimens are introduced into
the analyser in closed vessels. Dilution, mixing and measure-
ment are performed by the analyser, and the results are printed
out immediately after the analysis. An acetylene flame is used
for excitation. The intensity of light emission is measured after
selection of the appropriate wavelengths by interference filters.
The diluent contains a constant concentration of lithium, so
that the analyser determines the ratio of the two measurement
Signals, e. g. sodium/lithium, and compensates for any changes
of concentration that may have occurred during atomization
or introduction of the gases. The Instrument dilution System
mixes l part of sample with 50 parts of diluent. Standard
solution No. 0030310.004 from the manufacturer was used for
the calibration.
2.1.2 Ion-sensitive electrode unit in the Hitachi 717 automatic
analyser, Boehringer Mannheim
lon^sensitive electrodes (ISE) are constructed s flow-through
electrodes with fluid membranes on a PVC base. They contain
a crown ether for the determination of sodium, valinomycin
for the determination of potassium, and a quatemary ammo-
nium compound for the determination of Chloride. The analyser
pipettes 20 μΐ of sample into a dilution vessel, where it is mixed
with 600 μΐ of diluent (No. 820 636).lFinally, the diluted sample
is sucked into the ISE compartment until the electrodes are
covered by the solution. The activities of sodium, potassium
and Chloride are always measured simultaneously.
2.2 Determination of creatinine in mixed sera
Two different methods were used for the determination of
creatinine:
2.2.1 Manual determination of the creatinine concentration
In the test kit "Creatinine PAP" (Boehringer Mannheim, No.
839434) creatinine is hydrolysed to creatine by the action of
creatininase (EC 3.5.2.10). Creatinase (EC 3.5.3.3) then cata-
lyses the conversion of creatine to sarcosine and urea. In a third
stage, sarcosine is converted to glycine, formaldehyde and hy-
drogen peroxide by the action of sarcosine oxidase (EC 1.5.3.1).
Finally, in the presence of peroxidase, the hydrogen peroxide
reacts with 3,5-dichloro-2-hydroxybenzene sulphonic acid and
p-aminophenazone (PAP) to produce a red benzoquinonimine,
which is measured at 546 nm.
2.2.2 Creatine determination with the analysis System Hitachi
705
The method is based on a modification of the Jaffa reaction.
Creatinine forms a coloured complex with picrate in alkaline
solution, and the rate of formation of this complex is measured.
The test combination from Boehringer Mannheim (No. 704130)
was used for the assay.
2.2.3 Preparation of test material
Sera with very low creatinine concentrations (< 50 μπιοΙ/1) were
selected from the daily samples received by the clinical labo-
ratory, and combined into a serum pool. A second pool was
prepared in parallel, using sera with creatinine concentrations
between 1000 and 1500 μπιοΐ/ΐ. Using an HPLC procedure s
the reference method, the low creatinine pool (serum pool 1)
was found to have a concentration of 40.66 μιηοΐ/ΐ (Cl) and
the high creatinine pool (serum pool 2) contained 1169.09
μηιοΐ/ΐ (C2)3).
Separate 4 ml (vO samples of serum pool l were mixed with 0,
50, 100, 150, 200, 250, 300 and 350 ml (v2) of serum pool 2.
The creatinine concentrations of the 8 resulting serum mixtures
were calculated from: [(C, χ v,) + (C2 x v2)]/(vt + v2) = C3,
where the concentration (C) is in μιηοΐ/ΐ, and the volume (v) is
in ml.
The manufacturer quptes the follpwing measurement ranges: 2.3 Thyrotropin determination in mixed sera
sodium 80 — 180 mmol/1,
potassium 1.5— 10 mmol/1,
Chloride 60 —120 mmol/1.
Before and after each sample me surement, the ISE System is
recalibrated with an internal Standard solution (No. 820 644).
Once daily, befqre operations begin, calibration is performed
with two Standard Solutions (low, No. 646911; high, No.
646938), and a compensator (Np. 917656).
2.1.3 Preparation of test material
A series of sodium Chloride dilutions was prepared s follows.
The Contents of an ampoule of sodium-standard solution Ti-
trisol® (Merck Darmstadt, No. 9927), cpntaining 1.000 g so-
dium s sodium Chloride, was washed into a 250 ml Volumetrie
flask with double distilled water and adjusted to the calibration
mark. The resulting solution contained 173.989 mmol/1 Na+.
Two commercial thyrotropin reagent kits were available for the
determination pf serum thyrotropin. One of these assays uses
125I-labelled antibody, and the radioactivity was measured in a
gamma counter (MR 252, Kontron AG, ZH). In the second
assay, the label is a luminogen, and the luminometer, Clinilu-
mat® LB 9501 (supplier: Dr. Berthold, Wildbad), was used for
the luminescence measurements.
2.3.1 Radioimmunoassay of thyrotropin using two monoclonal
antibodies (Henning Berlin)
In this radioimmunoassay, two monoclonal antibodies recog-
nize two different determinants of the antigenic human thyro-
tropin. One of the two antibodies is labelled with I25I, and the
3) The authors are very grateful to Dr. Leinberger, Boehringer
Mannheim, for these determinations.
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other is bound to the surface of minute plastic particles. About
3.6 χ l O9 particles are added tocach assay tube, corresponding
to a total surface area of 114 cm2. Free, I25I-labelled antibody,
fixed antibody and lest material are incubated together at room
temperature; the resulting Sandwich complex remains fixed to
the microparticles. After incubation, the reaction solution is
diluted and the bound fraction is sedimented by centrifugation.
The radioactivity of the microparticle pellet is proportional to
the thyrotropin concentration. The lower limit of the assay is
0.03 mU/1. The WHO Standard 2 IRP 80/558 was used s the
reference Standard.
2.3.2 Lwninescence immunoassay (Byk-Mallinckrodt)
In this assay, a monoclonal antibody is bound cov lently to
the inner waU of the assay tube. The antigenic human thyro-
tropin of the sample or Standard binds to the monoclonal
antibody, A second monclonal antibody is then added, which
is labelled with a luminogenic molecule. During the incubation,
a sandwich is formed, which remains in the assay tube when
the excess solution is removed by aspiration. After washing,
the drained assay tube is placed in the luminometer; catalyst
solution and alkaline peroxide solution are added, and the
resulting light emission is measured. Using the emission intens-
ities of the Standards, the apparatus performs an internal cali-
bration, and uses this to automatically calculate the thyrotropin
concentrations of the test samples.
2.3.3 Preparation of test material
Sera with relative high thyrotropin concentrations were selected
from the daily samples received by the clinical laboratory, and
combined into a serum pool (high thyrotropin pool). Similarly,
sera with very low thyrotropin concentrations were combined
into a low thyrotropin pool. The respective concentrations of
the two pools were determined in an independent reference
laboratory4), using the RIA-gnost TSR (Behring-Werke) s the
reference method. The reference Standard was TSH WHO 80/
558. The high thyrotropin pool was found to contain 46.46
mU/1, and the low thyrotropin pool contained 0.016 mU/1.
From the two pools, 8 mixtures were prepared according to
the following scheme:
No.
10
9
8
7
6
5
4
3
2
1
High
thyrotropin pool
1
1
Previous
dilution
1
1
1
1
1
1
1
0
-f Low
thyrotropin pool
+ 0
+ 1
Low
thyrotropin pool
+ 3
-f 9
-l· 1
+ 1
+ 1
-f 1
+ 1
+ 1
Theoretical
concentration
(mU/1)
46.46
23.238
5.8215
0.5965
0.3063
0.1611
0.0886
0.0523
0.0341
0.016
2.4 Procedure for the evaluation of analytical pre-
cision and accuracy
In all the tested methods, the calibrators recommended or
supplied by the manufacturer were used. These calibrators meet
4) The authors are very grateful to Prof. J. J. Staub and Dr.
H. Engler (Endocrinology Division, Centre for Interaal Med-
iane of the University of Basel) for the analyses, and to Dr.
L. Bors, Director of Behring Hoechst (Switzerland) for pro-
viding the reagents.
the requirenients of B ttner et al. (16) and Stamm (17), i.e. that
calibrators should be . independent of the test material under
mvestigation.
Each of the 11 sodium test Solutions, the 8 creatinine test
Solutions, and the 10 or 9 thyrotropin test Solutions were
analysed 10 times "within run", and the average values and
Standard deviations caloulated from the resuits.
The 10 identical specimens in each 10 fojd "within run" deter-
mination were analysed directly one after the other, so that the
resuits were not aflfected by carry-over.
2.4.1. Average va/ite (,\) and Standard deviation (x) wcrc caN
culaled in the convcnlional way:
χ = (l/n) Σ s = [Σ (* - x)2/(n - l)f5
The relative Standard dcviation, i.e. thc so-caMcd cocfficicnt
of Variation (CV) was normally calculated s percentage CV:
CV% = 100 (s/x).
2.4.2 Regfession lines and correlation coefficients were estimated
by principal component analysis according to Feldmann et al.
(18) or by linear regression analysis. A Computer program was
available for construction of the regression line of Passing &
Bablok (19).
2.4.3 Bios was determined from: Bias = χ — μ. The relative
bias or coefficient of bias (CB%), which is analogous to CV%,
was determined from: CB% = 100 (χ — μ)/μ.
2.5 Graphical procedure for the evaluation of pre-
cision and accuracy, and their dependency on analyte
concentration
The following graphs were produced by entering the values of
μ, χ and s in a specially written program for a PC (Hewlett
Packard 87XM).
2.5.1 χ vs s.
2.5.1.1 The "Sadler curve" (corresponding to fig. l a).
2.5.1.2 Transformation of 2.5.1.1 to χ vs CV% (corresponding
to flg. Ib).
2.5.2 μ vs (χ - μ).
2.5.2.1 The appropriate regression line according to Lc. (19).
2.5.2.2 The required interval limits; for this purpose the "in-
terval factor" for s must be calculated externally and
entered separately each time, e. g. for the bias profile:
ta/l/n for the deviation profile: t« l/l -f l/n (corre-
sponding to fig. Ic).
2.5.2.3 Transformation of 2.5.2.2 to: μ vs (χ - μ)/μ χ 100*
with the accompanying transformed intervals (corre-
sponding to fig. Id).
These 4 presentations were chosen in a dialogue with the Com-
puter, in which the program asks whether the abscissa should
be linear or logarithmic, which concentration r nge 'should be
covered, which scale or scale interval should be shown on the
Ordinate, etc.
According to choice, the graph can be presented with or withput
a grid, and many different Symbols are available for represen-
tation of the points.
The plot of 2.5.1.2 represents the "predsion profile", while
2.5.2.3 represents the "bias profile" r "deviation profile".
DifTerent lines (continuo s, dotted, etc.) caa be selected for the
plot, and the accompanying invervals can be hatched. The
graph is produced on a VDU or plotter, so that multicoloured
graphies are also possible.
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Tab. 2. Data base from the evaluation of the flame photometer and the ISE System for the determination of sodium concentration/
activity.
(mmol/l)
87.0
91.6
96.7
102.3
108.7
116.0
124.3
133.8
145.0
158.2
174.0
Flame photometer
X
(mmol/l)
90.06
94.71
99.39
104.90
111.88
117.74
125.42
134.40
144.48
156.50
169.66
s
(mmol/l)
0.259
0.152
0.208
0.205
0.253
0.331
0.244
0.485
0.193
0.440
0.381
CV
(%)
0.29
0.16
0.21
0.19
0.23
0.28
0.19
0.36
0.14
0.28
0.22
CB
(%)
3.52
3.39
2.78
2.54
2.60
1.50
0.90
0.45
-0.36
-1.07
-2.49
ISE
X
(mmol/l)
89.7
94.3
99.3
105.0
111.1
118.2
126.6
136.1
147.3
159.3
175.3
s
(mmol/l)
0.483
0.483
0.483
0.471
0.316
0.632
0.516
0.738
0.483
0.527
0.483
CV
(%)
0.54
0.51
0.49
0.45
0.28
0.53
0.41
0.54
0.33
0.33
0.28
CB
(%)
3.10
2.95
2.69
2.64
2.21
1.90
1.85
1.94
1.59
0.70
0.74
3. Results
3.1 Determination of sodium concentrations
and activities
Comparison of the results of the two analytical Sys-
tems is restricted by the fact that sodium concentra-
tions differ from Na+ activities, even in pure aqueous
Solutions. Moreover, on no account can the results
for sodium analysis in aqueous solution be used to
interpret analyses in biological materials (plasma,
serum, urine, etc.). Table 2 shows the theoretical val-
ues, average values and Standard deviations, äs well
äs the calculated CV% and CB%.
3.1.1 The within-run precision, expressed äs CV%, is
far less than 0.5% for flame photometry, and less
than 1% for the ISE system. In flame photometry,
the symmetrical variätions, CB%, decrease from
+3.5% to —2.5% with increasing concentration; in
the ISE system, this decrease is less pronounced (from
+3.1% to +0.74%).
3.1.2 The compensatory regression line for the plot of
the ISE values against the theoretical values is shpwn
in figure 2, together with the correlation coefficient.
It can be seen that all the pöints lie exactly on the
compensatory regression line, which for the ISE Sys-
tem shows a slope of 0.98 and an intercept of +4.1
mmol/l. For flame photometry, the slope is 0.99, with
an intercept of 2.1 mmöl/1. In both Systems the cor-
relatipn coefficient for the theoretical"values is greater
than 0.999. The regression equations and correlation
coefficients of the four possible combinations are
given in table 3.
3.1.3 The graph of Standard deviations against average
values is shown in figure 3a. Sadler curves were con-
structed from each set of pöints. As the average values
increase over the measurement ränge, their accom-
panying Standard deviations also increase. This in-
200
? 160
; 120
80
40 80 120 160
Sodium (assigned value) [ m m o l / l ]
200
Fig. 2. Regression line (principal component analysis): assigned
values ( ) vs mean values of sodium, obtained by ion
sensitive electrode measurements (y).
y = 0.984 + 4.13, r > 0.999.
Tab. 3. Regression equations from the data of table 3.
FlaPho = flame photometry
Regression functions y = a
y ax
FlaPho = 0.987
ISE = 0.984
ISE = 1.070 FlaPho
FlaPho = 0.935 ISE
+ b
tb
+2.13
+4.13
-7.27
+ 6.80
Correlation
coefficient r
0.999
0.999
0.999
0.999
crease is about 0.2 mmol/l for flame photometry, but
much less for the ISE system.
In contrast, the precision profile (fig. 3b) for flame
photometry is almost parallel to the concentration
axis over the whole measurement ränge, whereas the
precision profile of the ISE system describes a curve
which falls from 0.55% to 0.3% with increasing Na+
activity.
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Tab. 4. Data base for the evaluation of methods for the determination of creatinine.
μ(μιηοΐ/ΐ)
40.66
54.59
68.18
81.45
94.39
107.04
119.39
131.45
Hitachi 705
Χ ί
(μιηοΐ/ΐ) (
54.5
67.3
81.6
93.6
107.4
118.0
129.2
140.3
;
μιηοΐ/ΐ)
.51
.34
.58
2.07
.51
.15
.72
1.54
CV
(%)
2.77
1.99
1.93
2.21
1.41
1.97
1.33
1.54
CB
(%)
34.04
23.28
19.68
14.92
13.78
10.24
8.22
6.73
Manual
X
(μπιοΐ/l)
47.86
58.57
68.67
80.78
89.24
105.00
118.43
129.92
s
(μιηοΐ/ΐ)
4.24
3.43
1.56
2.08
3.37
3.14
3.52
3.89
CV
(%)
8.86
5.86
2.27
2.57
3.77
2.99
2.97
2.99
CB
(%)
17.70
7.29
0.72
-0.82
-5.46
-1.90
-0.80
-1.16
3.1.4 Theplot of the differences (Xj — μί) (i. e. the bias)
against the theoretical values (fig. 3c) shows a contin-
uous linear decrease from about +3.0 mmol/1 to — 3.0
mmol/1 for flame photometry. In contrast, the bias of
the ISE system decreases only slightly, i. e. from 2.7
to 1.3 mmol/1. However, the intervals (calculated ac-
cording to Eq. 3 and Eq. 4) for flame photometry are
markedly narrower than those for the ISE System.
The relative deviations of accuracy are shown in figure
3d. Both analytical methods produce gently decreas-
ing convex curves, which are more pronounced for
the flame photometer than for the ISE System. Below
145 mmol/1, the two profiles increasingly overlap,
whereas above 145 mmol/1 they become increasingly
differentiated.
3.2 Determination of creatinine
Table 4 shows the theoretical values, together with
the average values, Standard deviations and CV%
and CB% values produced by each of the tested
analytical Systems.
3.2.1 It can be seen that the lowest within-run preci-
sion, expressed s CV%, is obtained with the Hitachi
705. With both Systems, the Variation coefficient de-
creases with increasing creatinine cpncentr tio . The
systematic variations, CB%, also decrease with in-
creasing creatinine concentration. For both Systems,
the percentage systematic variations are much greater
than the percentage imprecisions.
3.2.2 The regression line and correlation coefficient of
the manual method are shown in flgure 4. The ana-
lytical values are narrowly scattered around a regres-
sion line, which has a slope of 0.91 and an intercept
of +7.8 μφοΙ/L Table 5 shows the regression equa-
tions and correlation coefficients, the latter being
greater than 0.99 for all three Systems.
140
.120
100
Ι 80
.£ 60
'S
40
40 60 80 100 120
Creatinine (assigned value) [μπιοΙ/Π
140
Fig. 4. Regression line (principal component analysis): assigned
values (μ) vs mean values of creatinine, obtained by
Creatinine PAP, Boehringer Mannheim, manual method
(y).
y = 0.912 μ + 7.85, r = 0.996.
Tab. 5. Regression equations from the data of table 4.
Hi = Hitachi
Regression function: y = a χ -
y ax
Manual = 0.912 μ
ΗΪ705 = 0.949 μ
Hi705 = 1.035 man
Manual = 0.955 Hi
h b
b
+ 7.85
+ 16.26
-h 8.63
- 7.20
Correlation
coefficient r
0.996
0.999
0.994
0.994
3.2.3 Figure 5a shows a plot of Standard deviation
against the average values. In both methods, the as-
sociated Sadler curves increase with increasing cre-
atinine concentration. It can be seen that the impre-
cision of the Hitachi System is lower than that of the
manual proced re.
If these curves are transformed to relative impreci-
sions (fig. 5b), it becomes very clear how the relative
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imprecision of each System deoreases with increasing
creatinine concentration. The percentage Variation
coefficient is generally less than 2.5% for the Hitachi,
and generally less than 5% for the manual procedure.
3.2.4 Figure 5c shows the absolute difference between
average and theoretical values plotted against the the-
oretical values. In both methods, the regression line
of these differences tends to* fall with increasing cre-
atinine concentrations. This graphical representation
shows that the manual method is more accurate than
the Hitachi System in the investigated concentration
r nge. Conversely, the points in the plot for the Hi-
tachi system are less widely scattered. The lower limit
of the intervals for the Hitachi system is practically
identical with the upper limit fo the intervals for the
manual method.
In figure 5d, the relative differences between average
and theoretical values are plotted against the theoret-
ical values. The relative Sadler curves are convex, and
they fall with increasing creatinine concentration.
Their associated deviation limits decrease with in-
creasing creatinine concentration. Between 90 μιηοΐ/ΐ
and 165 μηιοΐ/ΐ, the deviation limits of the manual
method are less than ± 10%. The analytical values
of the Hitachi system are systematically higher than
the nominal values determined by HPLC. The results
of the manual method, however, show a close corre-
spondence with the target values, notwithstanding the
fact that they also show a relative increase with de-
creasing creatinine concentration.
3.3 Determination
tration
of thyrotropin concen-
Table 6 shows the the theoretical values, average
values and Standard deviations of the two tested im-
munoassays.
3.3.1 Over the tested r nge, the Standard deviation of
both methods increases with increasing thyrotropin
concentration. The lowest Standard deviation was al-
ways found with the lowest thyrotropin concentra-
tion, and the largest Standard deviation with the high-
est thyrotropin concentration.
3.3.2 The results of the radioimmunoassay are plotted
against those of the reference method in figure 6,
which also shows the correlation coefficient. Only
three points are shown; the remaining points lie below
l mU/1, and they are therefore invisible. Table 7 shows
the regression functions for the two tested assays.
Although the gradient of the RIA is about l, and
that of the LIA is only 0.6, both methods show very
high correlation coefficients.
100
80
'S 40
l
20
20 40 60 80
Thyrotropin (assigned value) [mU/l]
100
Fig. 6. Regression line (prineipal component analysis): assigned
values (μ) vs mean values of thyrotropin obtained by
radioimmunoassay (y).
y = 1.062 μ - 0.265, r = 0.997.
Tab. 6. Data base for the evaluatipn of methods for the determination of thyrotropin.
μ(mU/l)
0.016
0.0341
0.0523
0.0886
0.1611
0.3063
0.5965
5.8215
23.238
46.46
RIA
χ
(mU/l)
0.005
0.016
0.067
0.088
0.142
0.244
0.445
4.927
21.27
50.632
s
(mU/l)
0.0108
0.018
0.020
0.010
0.021
0.021
0.021
0.055
0.402
1.155
CV
• (%)
216
112.5
29.85
11.36
14.79
8.61
4.72
1.12
1.89
2.28
CB
(%)
-68.75
-52.79
28.11
- 0.68
-11.85
-20.34
-25.39
-15,37
- 0.08
8.98
LIA
X
(iiiU/l)
0.068
0.085
0.079
0.085
0.138
0.178
0.348
3.591
•A
30.791
s
(mU/l)
0.01
0.013
0.013
0.020
0.037
0.036
0.058
0.238
•A
2.059
CV
(%)
14.71
15.29
16.46
23.52
26.81
20.22
16.67
6.63
•A
6.69
CB
(%)
325
149.26
51.05
- 4.06
-14.34
-41.89
-41.66
-38.31
V-
-33.73
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Tab. 7. Regression equations from the the data of table 6.
Regression function: y = a
y ax
RIA = 1.0621
L1A = 0.6623
LIA = 0.6068 RIA
RIA = 1.6476 LIA
+ b
b
-0.2646
-0.1043
+0.1157
-0.1896
Correlation
coefficient r
0.997
0.999
0.999
0.999
3.3.3 The Sadler curves for the plots of Standard
deviations against the average values are shown in
figure 7a. Up to an average value of l mU/1, these
curves run strictly parallel to the abscissa, and are
more or less identical. Above this value, however, they
rise rapidly, and at 10 mU/1 they are distinctly sepa-
rated. Both curves show a good fit to the points, and
their apparent massive rise with increasing thyrotro-
pin concentration is due to the logarithmic scale of
the abscissa.
In contrast, the precision profiles, äs expected, de-
crease with ijicreasing thyrotropin concentration (fig.
7b). After passing through a minimum, they both
increase again slightly (the LIA rather more than the
RIA) above 10 mU/1. At 0.1 mU/1, the precision
profile of the RIA is still less than 20%, whereas the
precision profile fo the RIA is greater than 30%. At
concentrations greater than 1.0 mU/1, the precision
profiles of both assays lie below 10%.
3.3.4 The absolute difference between reference values
and experimental results are plotted against theoret-
ical values in figure 7c. Up to l mU/1, the plots for
the two assays are more or less identical, and they
show extremely close agreement with the reference
method. Above l mU/1, the plots slope downwards,
äs both methods increasingly diverge from the refer-
ence method.
The relative deviations of accuracy are shown in figure
7d. Below l mU/1, the imprecision of both assays
increases exponentially. Below 0.1 mU/1, both assays
produce useless values. On the other hand, both assays
show their narrowest deviation ranges at about
5 mU/1, and these increase markedly again at higher
concentrations. Between l and 100 mU/1, the RIA
produces values that are systematically slightly less
than those of the reference method, whereas the values
from the LIA are about 40% lower than the reference
values.
4. Discussion
For the evaluation of analytical methods, Büttner et
al. (16) put forward the IFCC recommendations.
These include procedures for the determination of
analytical precision and accuracy. It is stressed that
the imprecision of the lower, intermediate and upper
parts of the analytical ränge should be considered
separately, and that correlation coefficients and
regression equations are of little value for comparing
the inaccuracy of two methods. Instead, it is feconi-
mended that two methods be compared by plotting
the differences between test an& reference method
against the average values.
Similar approaches are formulated in the ECCLS
recommendatiön for the "Evaluation of Analyses in
Clinical Chemistry" (20) and in the NCCLS recom-
mendations for "Comparison of quantitative clinical
laboratory methods" (21).
In practically all contemporary descriptions of meth-
ods, or reports of method comparisons, data are pre-
sented on imprecision (intra-assay, between-day, etc.).
These are based on measurements of two or three
commercial control materials, whose conceütrations
usually do not lie in the upper or lower limits of
detection of the method under investigatioii. Accuraey
is also tested with eommercial control materials, and
the results are compared with those claimed by the
suppliers. When methods are compared, the concen-
tration of an analyte is determined with the test and
reference method on a number of patient sera; the
results from the respective methods are plotted against
each other, a regression line is drawn, and the relevant
cqrrelation coefficient is calculated. If, äs a first ap-
proximation, the points lie on the regression line, the
correlation coefficient is high and the imprecision is
low; the tested method is then declared to be reliable,
and to show a close correlation with the reference
method.
The lower and upper measurement limits are usually
not determined, and no distinction is drawn between
the lower detection limit and the lower limit of the
analytical ränge. The dependeiicy of precision and
accuracy on concentration is nearly älways over-
looked, despite the fact that even Standard text books
state: "the Standard deviation may Vary with the level
of the substance being determined (24)", and: "the
random error distributions are seeü to vary with the
concentration of the test material... this is a common
occurrence in clinical chemical assays and is virtually
the rule with radioimmunoassays" (25).
The theoretical basis of this approach is questioned,
not only by the IFCC recommendations, but also by
the work of Blond and Altmann (22, 23)^ In practical
terms, the poor correlation of results from differerit
laboratories shows that current procedures for de-
scribing and comparing methods are often inade-
quate.
J. Clin. Chem. Clin. Biochem. / Vol. 27,1989 / No. 9
Keller and Passing: Performance profiles 625
E
ι!
S O O«O ·**·
1%) AD 'υομουοΛ jo
t
\
E
<M tr» o»=·· τ-'
s'uoijoiAap
εε
2
cl
Ϊ
Cd
X^V
<
2
X
g
-ff
^o
rt
•c
t
1
s
00
cd
•o
00
cd
C
l 2 ,- g
X
v··'
5
OO
1
3
ε;§
Ό2£
00
.2
"•£3
esβ
1D
1
jj
'S.
2
8
>»X
<L)
£|C*·*
42 x-s
M ·>Q^ HH
«^ Λ
<L> O
«3 1
<^ ^Ο Ό
C S
.0 fO
,α v>
S-2
O "cd3§ S
.er
00
B
C3
^er
. U
.S ε
·> S
•^  o 'n^
<Λ.% - .2 C«
^ > bO.£> .±i
de
vi
at
io
ns
St
an
da
rd
£
IX
I
Cta«
J13>
I
<f
*t?
&
ta
nd
ar
d 
de
1s 
ac
co
rd
in
v» cd
« ε£ sC
"S?'I
IX <Λ
^ «J
'S2§^
«2 3.
11
c ^
S Hε ω
o|<«-< „
S ^u
o 2
^ ^00 -C
cd *-
S-o
> *
3*8
Ϊ-
A «>
«-X
!^II
e'ucT^
• J3 .1-1 <
o" o
c^
•s «
& 2
J. Clin. Chem. CHn. Biochein. / Vol. 27,1989 / No. 9
626 Keller and Passing: Performance profiles
The procedure described in the present work repre-
sents an extension of the IFCC recommendations.
The most important characteristics of the perform-
ance of a clinical chemical method are displayed by
drawing a graph of accuracy and precision over the
whole or part of the analytical ränge.
A combination of bias and Standard deviation, äs
recently described by Londerback et al. (26), was in-
tentionally avoided, because, äs stated by Currie (25),
these two parameters "must be viewed äs two com-
ponent vectors".
With the aid of the deviation profile, the lower and
upper limits of the measurement ränge of a clinical
chemical method can be clearly established by defin-
ing the limits of deviation. The limits of the measure-
ment ränge are then defined by those points at which
the limits of deviation are exceeded. As pointed out
frequently by Stamm (27, 28), these limits must make
sense in terms of the clinical purposes of the assay.
Neither "the dynamic ränge of System response" (21),
nor the customary estimation of (deviations from)
linearity, are appropriate criteria for establishment of
the measurement ränge.
Without doubt, the described experimental procedure
is demanding and occasionally difficult to realize. This
is clearly shown by the evaluation of the methods for
the determination of sodium concentration and activ-
ity. Patient sera with very low or very high sodium
concentrations, which would be suitable for prepa-
ration of the dilution series, are seldom encountered.
We therefore resorted to an aqueous calibrator. The
results therefore do not represent those obtained with
biological matrices, and despite the fact that they
show splendid reproducibility, they are only valid äs
a model.
The comparative studies on the determination of cre-
atinine and thyrotropin are nearer to reality. Even
here, there should be an awareness of the fact that
changes occur in the matrix whenever two sera are
mixed to produce a new test concentration of analyte.
It can also be argued that only the intra-assay impre-
cisions are used. Determination of day-to-day impre-
cision is, however, very time-consuming, so that mul-
ticentre evaluations are probably more appropriate.
Each test laboratory would then prepare its own pool
sera and its own dilution series.
In the present investigation, all regression analyses
revealed a linear relationship between the test and
reference method, and all correlation coefficients were
greater than 0.99. These correlation coefficients are,
however, artificially high, because the x/y values are
not normally distributed over the whole scale.
On the other hand, the graphical representation of
the bias and deviation profiles gave a different picture.
Thus, the results from the flame photometer indeed
show high precision, but they become very inaccurate
in the upper and lower part; the ISE results are less
precise, but have a smaller bias.
The mechanized creatinine detemnination has a very
low imprecision, but it deviates considerably from the
true values, especially in the lower ränge. Better results
are obtained with the manual, enzymie method. Sim-
ilar fmdings have been published by Guder et al. (29),
who presented intra-assay- and between-day-impre-
cision profiles for this method, based on the results
of a multicentre evaluation. The plot of their intra-
assay precision profile is very similar to our figure 5b.
Analytical values produced by the tested method for
thyrotropin sometimes differed considerably from
those of the reference method. More significantly,
however, the imprecision and inaccuracy increase be-
low l mU/1, until the results become useless for di-
agnostic purposes below 0.1 mU/1. This result is con-
firmed by recent results of othef authors, who, how-
ever, reported only precision profiles (30, 31).
What are the implications of presenting analytical
accuracy and precision in the form of bias profiles
and deviation profiles?
In accordance with the ECCLS recommendations, a
comparison of methods, or the investigation of the
Performance of a method, even with the aid of bias
profiles and deviation profiles, is valid only if per-
formed by several laboratories in a multicentre eval-
uation. Different matrices and different interfering
factors must be investigated, and this is achieved by
using different pool sera for the preparation of test
series of dilutions.
The mathematical-statistical bases for the construc-
tion of bias profiles and deviation profiles are given
in the appendix.
Other characteristics of clinical chemical methodol-
ogy, which have not been touched upon by the present
work or discussion, but nevertheless should be inves-
tigated, are analytical specificity, the influence of in^·
terfering factors, carry-over, practicability, and oper-
ational costs in terms of time and money, etc.
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Appendix
In the present work it is essential to distinguish be-
tween confidence intervals and tolerance intervals.
Both terms are therefore discussed here in context,
using the terminology of DIN (32, 33, 34).
Let the true concentration of the analyte in the sample
be , and let the expected value, äs determined by the
chosen method, be EX. The theoretical bias of the
method is then EX — , and this represents the
systematic deviation. Whereas 5s known a priori.
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EX is unknown and must therefore be estimated by
independent measurements.
If Χι, ..., Xn represent independent, normally distrib-
uted, random variables, then we write:
Let Δ be a predetermined limit of deviation, i. e. a
deviation that is still acceptable for practical purposes.
The associated measurement r nge then consists of
all those conceiitrations for which the following re-
lationship is valid:
Xlf ..., N(EX, σ2)
A confidence interval (C) is always aimed at a param-
eter of the underlying distribution, or at a quantity
derived from it, e. g. at the bias EX — μ. C is cal-
culated from Xl5 ..., Xn, and it contains the unknown
quantity with a predetermined probability l — a:
P{EX - μ 6 C|X1? ..., Xn} = l - a
According to Eq. 3, C is given by:
(X - μ) ± t« · s
It is seen that the width of C decreases towards zero
s n increases.
If X is an analytical value determined with the method
under lest, then X — μ represents the total deviation
of this measurement:
X - μ = (X - EX) + (EX - μ)
i. e. the total deviation of the measurement consists
of the sum of random deviation and the bias of the
method.
A tolerance interval, T, is always an estimated r nge,
in which the random variable, X, or a variable derived
from it, e. g. X — μ, varies in accordance with the
distribution of X. T is also calculated from X,, ...,
Xn, and it contains X — μ with a predetermined
expected probability of l — a:
- μ) ± t. - s - / l + -l < Δ
In order to clarify further the differences between C
and T, the derivation of the formulae for C and T
should be considered. The derivation Starts with:
X = - Σ X; ~ N (EX, —
n i i \ n
S2 =
n — l i = iΣ (Xi ~ X)
2
Now, let t be a jSfwdenf-distributed random variable
with (n — 1) degrees of freedom, and let t« be its two-
sided critical value for probability l — a; then:
EP{X - ι, ..., Xn} = l - a
(Tolerance intervals with confidence probability will
not be discussed here). According to Eq. 4, T is given
by:
X - EX ~ N ( 0 , —
X - EX
-™ ~ t
s
Since X - EX = (Χ ^  μ) ~ (EX - μ), it follows
that
ρ||(Χ_μ)-(ΕΧ-μ)|<ν8· Α| = 1-α
The confidence limits for EX — μ are therefore
(X - μ> ± t. · s
Further:
X - X - N (θ, σ2 (l + M
X ~ X
The width of T does not tend to zero.
~ t
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Since Χ-Χ = (Χ-μ)-(Χ-μ)ίί follows that
The tolerance limits for X — μ are therefore
( X - u ) ± t . - s · l +-
It can be seen that for n ^ 10, these limits show little
dependence on n only. This is important, because it
is obvious that the limits of an analytical r nge must
not depend on n.
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